Clinical Trials Study
Copyright ©The Author(s) 2025.
World J Cardiol. Apr 26, 2025; 17(4): 104396
Published online Apr 26, 2025. doi: 10.4330/wjc.v17.i4.104396
Table 1 Related mean sample power analysis
n2Actual power3Test assumptions
Power
Effect size
P value
Test for mean difference1540.9500.950.50.05
Table 2 Related Pearson correlation power analysis
nActual power2Test assumptions
Power
Null
Alternative
P value
Pearson correlation1460.9540.9500.50.05
Table 3 Study participants selection criteria
Inclusion criteria
Non-inclusion criteria1
Exclusion criteria2
Participants age ≥ 40 yearsPregnancy and breastfeedingFailure of the stress test for reasons unrelated to heart disease
Participants with intact mental and physical activityDiabetes mellitusReluctance to continue participating in the study
Written consent to participate in the study, take blood samples, and anonymously publish the results of the studyPresence of signs of acute coronary syndrome (myocardial infarction in the prior 2 days), history of myocardial infarction
Participants in the experimental group are individuals with coronary artery disease, confirmed by stress-induced myocardial perfusion defect on the adenosine triphosphate stress myocardial perfusion computed tomographyActive infectious and non-infectious inflammatory diseases in the exacerbation phase
Respiratory diseases (bronchial asthma, chronic bronchitis, cystic fibrosis)
Acute thromboembolism of pulmonary artery branches
Aortic dissection
Critical anatomical heart defects
Active oncopathology
Decompensation phase of acute heart failure
Neurological pathology (Parkinson’s disease, multiple sclerosis, acute psychosis, Guillain-Barré syndrome)
Cardiac arrhythmias that do not allow exercise ECG testing (Wolff-Parkinson-White syndrome, Sick sinus syndrome, AV block of II-III-degree, persistent ventricular tachycardia)
Diseases of the musculoskeletal system that prevent passing a stress test (bicycle ergometry)
Allergic reaction to iodine and/or adenosine triphosphate
Table 4 Features of the continuous variables of the sample represented in the table
Variable
Mean (Min; Max)
SD
Age (year)56.28 (40.24; 77.94)10.601
Pulse rest (beat/minute)70.29 (49.00; 93.00)9.559
SBP rest (mmHg)123.16 (54.00; 159.00)15.437
DBP rest (mmHg) 80.61 (60.00; 122.00)11.238
Body weight (kg)77.92 (52.50; 140.00)16.236
Height (cm)169.95 (148.00; 190.00)8.835
BMI (kg/m2)26.93 (18.49; 48.44)4.901
Pulse rest (beat/minute)69.68 (49.00; 99.00)9.260
Pulse after stress (beat/minute)86.89 (63.00; 115.00)10.579
Goal heart rate (beat/minute)163.72 (142.06; 179.76)10.601
Max HR146.25 (108.00; 199.00)14.111
Reached %89.53 (64.89; 135.25)9.166
WT125.63 (75.00; 250.00)44.111
METs6.67 (2.90; 11.90)1.977
EF (%)85.28 (60.50; 104.50)8.358
Vessel age (years)56.50 (20.00; 80.00)13.520
R-CAVI8.21 (4.80; 15.10)1.379
L-CAVI8.18 (4.80; 14.90)1.299
Mean CAVI8,194 (4,800; 15,000)1,331
RABI1.15 (0.86; 1.40)0.088
LABI1.15 (0.89; 1.42)0.084
Mean SBP B (mmHg)134.38 (105.50; 169.00) 13.086
Mean DBP B (mmHg) 85.28 (60.50; 104.50)8.358
BP RB [(SBP + DBP)/2] (mmHg)103.98 (75.00; 137.00)11.547
BP LB [(SBP + DBP)/2] (mmHg)104.54 (71.00; 136.00)10.534
Mean BP B (mmHg)104.26 (73.00; 136.50) 10.772
BP RA [(SBP + DBP)/2] (mmHg)108.39 (80.00; 137.00)12.553
BP LA [(SBP + DBP)/2] (mmHg)108.63 (81.00; 138.00)11.519
Mean BP A (mmHg)108.51 (81.50; 135.00)11.468
Mean ABI1.15 (0.88; 1.41)0.081
RTb80.53 (59.00; 152.00)13.441
LTb77.26 (58.00; 128.00)14.012
Mean Tb78.89 (59.00; 132.50)12.547
Right Tba86.26 (23.00; 117.00)16.232
Left Tba86.40 (24.00; 114.00)14.685
Mean Tba86.33 (23.50; 115.00)15.358
Lha (cm)148.17 (130.33; 164.47)7.182
haPWV (m/s)0.91 (0.67; 1.42)0.124
β-stiffness index from PWV2.83 (1.21; 7.04)0.813
Creatinine (µmol/L)82.74 (53.90; 138.00)16.014
eGFR (2021 CKD-EPI creatinine)85.31 (45.40; 113.70)14.684
Table 5 Features of the categorical variables of the participants
Index
Factor
Absolute value, relative value
GenderF39 (48.75)
M41 (51.25)
Obesity stageNormal30 (37.500)
Overweight29 (36.25)
1 degree20 (25.00)
3 degree1 (1.25)
SmokingYes14 (17.50)
No66 (82.50)
Concomitant diseasesYes41 (51.25)
No35 (43.75)
Missing data4 (5.00)
Atherosclerosis of the coronary arteryYes31 (38.75)
No49 (61.25)
Hemodynamically significant coronary artery atherosclerosis on the CTP (> 60% stenosis)Yes9 (11.25)
No71 (88.75)
Stress-induced myocardial perfusion defect on the CTPYes31 (38.75)
No49 (61.25)
Myocardial perfusion defect before stress ATP on the CTPYes26 (32.50)
No54 (67.50)
Atherosclerosis in other arteriesYes41 (51.25)
No32 (40.00)
Missing data7 (8.75)
Atherosclerotic vascular (namely)Carotid1 (1.25)
Carotid brachiocephalic bifurcation41 (51.25)
Missing data38 (47.50)
Carotid artery atherosclerosisYes39 (48.75)
No34 (42.50)
Missing data7 (8.750)
Brachiocephalic artery atherosclerosisYes37 (46.25)
No36 (45.00)
Missing data7 (8.75)
Arterial hypertensionYes40 (50.00)
No40 (50.00)
Stage of the arterial hypertensionI5 (6.25)
II20 (25.00)
III16 (20.00)
Degree of hypertensionDegree 119 (23.75)
Degree 213 (16.25)
Degree 39 (11.25)
Risk of cardiovascular diseaseLow27 (33.75)
Moderate27 (33.75)
High18 (22.50)
Very high8 (10.00)
SCAD from anamnesisYes3 (3.75)
No29 (36.25)
Missing data48 (60.00)
Blood pressure reaction type on stress testAsthenic4 (5.00)
Hypotonic4 (5.00)
Hypertonic8 (10.00)
Normotonic64 (80.00)
Functional class by WattFC-I8 (10.00)
FC-II9 (11.25)
No SCAD63 (78.75)
Functional class by METsFC-I6 (7.50)
FC-II10 (12.50)
FC-III1 (1.25)
No SCAD63 (78.75)
Reaction type to stress test (positive/negative)Negative42 (52.50)
Suspected21 (22.5)
Positive17 (21.25)
Reason for discontinuation of the stress testHorizontal ST depression > 1 mm8 (10)
Reach goal HR72 (90)
Tolerance to exertion on stress testLow2 (2.50)
Moderate43 (53.75)
Close to high8 (10.00)
High16 (20.00)
Very high11 (13.75)
CAVI degreeNormal (< 8)36 (45.00)
Borderline (8-9)22 (27.50)
Pathological (> 9)22 (27.50)
ABI degreeNormal76 (95.00)
Borderline2 (2.50)
Abnormal1 (1.25)
Noncompressible1 (1.25)
Biological estimated vascular ageNormal45 (56.25)
High35 (43.75)
CKD stageI35 (43.75)
II41 (51.25)
IIIa4 (5.00)
Table 6 Categorical variables
Index
Factor
Group 1 positive myocardial perfusion on the CTP (n = 31)
Group 2 negative myocardial perfusion on the CTP (n = 49)
P value
GenderF17 (54.83)22 (44.89)0.387
M14 (45.16)27 (55.10)
Obesity stageNormal12 (38.70)18 (36.73)0.988363
Overweight11 (35.48)18 (36.73)
1 degree8 (25.80)12 (24.48)
3 degree0 (0.00)1 (2.04)
SmokingYes7 (22.58)7 (14.28)0.342
No24 (77.41)42 (85.71)
Concomitant diseasesYes15 (48.38)26 (53.06)0.835
No12 (38.70)23 (46.93)
Missing data4 (12.90)0 (0.00)
Atherosclerosis of the coronary arteryYes16 (51.61)15 (30.61)0.061
No15 (48.38)34 (69.38)
Hemodynamically significant coronary artery atherosclerosis on the CTP (> 60% stenosis)Yes8 (25.80)1 (2.04)0.0021
No23 (74.19)48 (97.95)
Stress induced myocardial perfusion defect on the CTPYes31 (100.00)0 (0.00)< 0.0011
No0 (0.00)49 (100.00)
Myocardial perfusion defect before stress ATP on the CTPYes21 (67.74)5 (10.20408)< 0.0011
No10 (32.25)44 (89.79)
Atherosclerosis in other arteriesYes22 (70.96)19 (38.77)0.0061
No7 (22.58)25 (51.020)
Missing data2 (6.45)5 (10.20)
Atherosclerotic vascular (namely)Carotid1 (3.22)0 (0.00)0.347
Carotid. brachiocephalic bifurcation21 (67.74)19 (38.77)
Missing data9 (29.03)30 (61.22)
Carotid artery atherosclerosisYes20 (64.51)19 (38.77)0.0151
No8 (25.80)26 (53.06)
Missing data3 (9.67)4 (8.16)
Brachiocephalic artery atherosclerosisYes18 (58.06)19 (38.77)0.067
No10 (32.25)26 (53.06)
Missing data3 (9.67)4 (8.16)
Arterial hypertensionYes19 (61.29)21 (42.85)0.109
No12 (38.70)28 (57.142)
Stage of arterial hypertensionI4 (13.55)1 (2.04)0.079756
II6 (19.35)14 (28.57)
III9 (29.03)7 (14.28)
Degree of hypertensionDegree 110 (32.25)9 (18.36)0.098908
Degree 23 (9.67)10 (20.40)
Degree 36 (19.35)3 (6.12)
Risk of cardiovascular diseaseLow10 (32.25)19 (38.77)0.449429
Moderate8 (25.80)16 (34.70)
High8 (25.80)10 (20.40)
Very high5 (16.12)3 (6.12)
SCAD from anamnesisYes4 (12.90)1 (2.04)< 0.0011
No2 (6.45)25 (51.02)
Missing data25 (80.64)23 (46.93)
Blood pressure reaction type on stress testAsthenic2 (10.50)2 (4.08)0.072076
Hypotonic3 (15.80)1 (2.04)
Hypertonic1 (5.30)4 (8.16)
Mild hypertonic1 (5.30)0 (0.00)
Normotonic12 (63.20)42 (85.71)
Functional class by WattFC-I1 (3.22)7 (14.28)0.313
FC-II3 (9.67)6 (12.24)
No SCAD27 (87.09)36 (73.46)
Functional class by METsFC-I1 (3.22)5 (10.20)0.5568
FC-II3 (9.67)7 (14.28)
FC-III0 (0.00)1 (2.04)
No SCAD27 (87.09)36 (73.46)
Reaction type to stress test (positive/negative)Negative16 (51.61)26 (53.06)0.191007
Suspected11 (35.45)10 (20.40)
Positive4 (12.90)13 (26.53)
Reason for discontinuation of the stress testHorizontal ST depression > 1 mm2 (6.45)6 (12.24)0.385
Reach goal HR29 (93.54)42 (88.11)
Tolerance to exertion on stress testLow1 (3.22)1 (2.04)0.416079
Moderate20 (64.45)23 (46.93)
Close to high3 (9.67)5 (10.20)
High3 (9.67)13 (26.53)
Very high4 (12.90)7 (14.28)
CAVI degreeNormal (< 8)9 (29.03)27 (55.10)0.073757
Borderline (8-9)11 (35.48)11 (22.44)
Pathological (> 9)11 (35.48)11 (22.44)
ABI degreeNormal29 (93.54)47 (95.91)0.89381
Borderline1 (3.22)1 (2.04)
Abnormal1 (3.22)1 (2.04)
Biological estimated vascular ageNormal16 (51.61)29 (59.18)0.507
High15 (48.38)20 (40.81)
CKD stageI12 (38.70)23 (46.93)0.285103
II16 (51.61)25 (51.02)
IIIa3 (9.67)1 (2.04)
Table 7 Continuous variables
VariableMean
t valueP value
Yes
No
Age (years)59.930 ± 11.70853.967 ± 9.2312.5330.0131
Pulse rest (beat/minute)70.225 ± 10.74470.326 ± 8.844-0.0450.963
SBP rest (mmHg)124.483 ± 20.563122.326 ± 11.2270.6060.545
DBP rest (mmHg)82.354 ± 13.16479.5102 ± 9.8151.1040.272
Body weight (kg)77.129 ± 14.71678.420 ± 17.257-0.3440.731
Height (cm)169.806 ± 9.414170.040 ± 8.546-0.1140.908
BMI (kg/m2)26.707 ± 4.23127.065 ± 5.318-0.3160.752
Pulse rest (beat/min)69.645 ± 11.5169.693 ± 7.632-0.0220.981
Pulse after stress (beat/min)85.741 ± 11.88887.612 ± 9.720-0.7680.444
Goal heart rate (beat/min)160.069 ± 11.708166.032 ± 9.231-2.5330.0131
Max HR (beat/min)142.677 ± 17.666148.510 ± 10.918-1.8270.071
Reached %89.423 ± 12.09489.602 ± 6.844-0.0840.933
WT120.967 ± 47.035128.571 ± 42.389-0.7490.456
METs6.329 ± 2.0356.887 ± 1.929-1.2350.220
EF (%)64.478 ± 4.77564.547 ± 4.220-0.0600.951
eVessel age (years)61.225 ± 12.42253.510 ± 13.4472.5730.0111
R-CAVI8.580 ± 1.0397.971 ± 1.5181.9590.053
L-CAVI8.438 ± 0.9388.018 ± 1.4691.4180.160
Mean CAVI8.509 ± 0.9757.994 ± 1.4891,70450,092
RABI1.123 ± 0.1001.162 ± 0.076-1.9900.0491
LABI1.129 ± 0.0871.158 ± 0.080-1.5050.136
Mean SBP B (mmHg)137.983 ± 15.433132.091 ± 10.9191.9980.049
Mean DBP B (mmHg)86.919 ± 8.76884.234 ± 8.0031.4080.162
BP RB [(SBP + DBP)/2] (mmHg)106.419 ± 12.852102.428 ± 10.4841.5180.132
BP LB [(SBP + DBP)/2] (mmHg)107.096 ± 11.510102.918 ± 9.6381.7500.083
Mean BP B (mmHg)106.758 ± 11.940102.6735 ± 9.759901.6710.098
BP RA [(SBP + DBP)/2] (mmHg)110.645 ± 13.093106.959 ± 12.1171.2840.202
BP LA [(SBP + DBP)/2] (mmHg)111.290 ± 12.770106.938 ± 10.4391.6640.100
Mean BP A (mmHg)110.967 ± 12.371106.949 ± 10.6951.5400.127
Mean ABI1.126 ± 0.0901.160 ± 0.072-1.8570.066
RTb77.258 ± 10.23782.591 ± 14.851-1.7510.083
LTb74.161 ± 12.88179.224 ± 14.467-1.5890.115
Mean Tb75.709 ± 10.65080.908 ± 13.323-1.8320.070
Right Tba81.193 ± 16.27989.469 ± 15.520-2.2790.0251
Left Tba83.000 ± 14.73088.551 ± 14.390-1.6650.099
Mean Tba82.096 ± 15.38489.010 ± 14.878-1.9980.0491
Lha (cm)148.057 ± 7.652148.247 ± 6.947-0.1140.908
haPWV (m/s)0.953 ± 0.1180.886 ± 0.1202.4450.0161
β-stiffness index from PWV2.953 ± 0.6592.756 ± 0.8951.0560.293
Creatinine (µmol/L)80.378 ± 15.44784.233 ± 16.341-1.0490.297
eGFR (2021 CKD-EPI creatinine)84.854 ± 15.14685.589 ± 14.535-0.2160.828
Table 8 Bicycle ergometry
Chars
Point estimate
95%CI
AUC0.5070.388-0.625
Sensitivity0.4840.306-0.657
Specificity0.5310.392-0.673
Negative predictive value0.6190.465-0.758
Positive predictive value0.3950.238-0.553
Table 9 Ten most statically significant features

Feature
LASSO absolute coefficient
1q0_QTc0.0221996
2q0_Beta0.0211857
3q0_J80A0.0179913
4q0_Pan…300.0168176
5q0_SA0.013914
6dltq_01_SA0.0126805
7dltq_01_Sbeta0.0125996
8q0_TA0.0124491
9dltq_01_RA0.0116579
10q0_Sbeta0.0111864
Table 10 Single-lead electrocardiography (Cardio-Qvark) in the diagnosis of ischemic heart disease
Chars
Point estimate
95%CI
AUC0.6700.531-0.802
Sensitivity0.5160.333-0.695
Specificity0.7550.628-0.88
Negative predictive value0.7120.586-0.83
Positive predictive value0.5710.387-0.758